Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc

生物数学

售   价:
1436.00
发货周期:国外库房发货,通常付款后3-5周到货!
作      者
出  版 社
出版时间
2022年12月15日
装      帧
精装
ISBN
9780128228333
复制
页      码
250
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 50 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC presents updated information on how EGFR mutant lung cancers evolve to evade EGFR inhibitors, clinical strategies that identify these mechanisms, and how to implement newer therapeutic strategies to combat resistance and improve patient survival. As resistance to EGFR inhibitors is often through re-activation of MEK/ERK and PI3K pathways, or through loss of cell death responses, there is much overlap with resistance to targeted therapies in other paradigms, such as BRAF inhibitors in BRAF mutant melanoma, and HER2 inhibitors in HER2 amplified breast cancer. This book is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field who are interested in promising treatments for lung cancer.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个